US Stocks
/
Cabaletta Bio, Inc. Share Price

Cabaletta Bio, Inc. Share Price

NASDAQ: CABA | Micro Cap
$1.94
-$0.04 (-1.77%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cabaletta Bio, Inc. Stock Performance

Open
$1.94
Prev. Close
$1.98
Circuit Range
N/A
Day Range
$1.87 - $1.97
Year Range
$1.83 - $4.21
Volume
2,45,132
Average Traded
$1.92

Cabaletta Bio, Inc. Share Price Today

As of 9 October 2026, Cabaletta Bio, Inc.'s share price is $1.94. The stock opened at $1.94, compared to its previous close of $1.98. During today's trading session, Cabaletta Bio, Inc.'s share price traded between $1.87 and $1.97, with an average price of $1.92. Over the past 52 weeks, the stock has recorded a high of $4.21 and a low of $1.83. In terms of performance, Cabaletta Bio, Inc.'s share price has declined by 35.01% over the last six months and is down 46.41% on a year-on-year basis.

Cabaletta Bio, Inc. Share Price Chart

$1.87$1.97
L
Show Current Price
H

Cabaletta Bio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$155.07M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.07
Revenue (TTM)
$0.00
Return On Equity (TTM)
-86.10%
Profit Margin
N/A
Debt to Equity
0.09
Quarterly Earnings Growth YoY
-13.71%

Cabaletta Bio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$44.87-$41.92-$43.52-$51.02
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A6.57%-3.82%-17.23%

Cabaletta Bio, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$52.98-$67.68-$114.73-$167.86
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-27.75%-69.52%-46.31%

About Cabaletta Bio, Inc.

Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.

Cabaletta Bio, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.91
$1.94
+1.04%
Sep 2026
$2.98
$1.92
-43.53%
Aug 2026
$2.65
$3.40
+26.39%
Jul 2026
$3.12
$2.69
-13.78%
Jun 2026
$3.79
$3.12
-17.68%
May 2026
$2.90
$3.79
+26.97%
Apr 2026
$2.70
$2.98
+11.17%
Mar 2026
$3.21
$2.69
-19.37%
Feb 2026
$2.52
$3.33
+30.08%
Jan 2026
$2.15
$2.56
+16.63%
Dec 2025
$2.46
$2.19
-14.26%
Nov 2025
$3.54
$2.56
-29.28%

CABA Share Price FAQs

What is Cabaletta Bio, Inc. share price today?

chevron-up
Cabaletta Bio, Inc. share price today is $1.94 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Cabaletta Bio, Inc. stock?

chevron-up
The 52 week high of Cabaletta Bio, Inc. stock is $4.21, while the 52 week low is $1.83 as of 9 Oct '26.

What is CABA's market capitalisation today?

chevron-up
CABA market capitalisation is $155.07M as of October 9, 2026, at 4:05 am IST.

What is CABA's net income for the last quarter?

chevron-up
CABA's net income for the last quarter is -51.02B USD.

What is the 5 year returns of CABA?

chevron-up
The 5 year returns of CABA is -85.85% as on 9 Oct '26.

What is the high & low stock price of CABA today?

chevron-up
CABA stock price hit a high of $1.97 and low of $1.87 as of 9 Oct '26.

Can I buy CABA shares in India?

chevron-up
Yes. You can buy CABA in India by opening an international trading account.